Category Archives: News

IK Investment Partners acquires Acture Groep

ik-investment-partners

IK Investment Partners (“IK”), a leading Pan-European private equity firm, is pleased to announce that the IK Small Cap II Fund has reached an agreement to acquire a majority stake in Acture Groep (“Acture” or “the Company”) from the Company’s founders. Financial terms of the transaction are not disclosed.

Acture Groep is a unique collective of innovative businesses providing specialised outsourced services to Dutch corporates and temporary staffing agencies to manage cases of illness or disability in their workforces. The Company was founded by current CEO, Maudie Derks, and two other co-founders in 2008 with the purpose of reducing absenteeism and employer costs amidst the complex and evolving Dutch social security system.

Through an organic and inorganic diversification strategy, the leadership team have sought high quality brands to augment their offering, which now encompasses health assessments, administration and reintegration services and independent insurance advice. IK will acquire its stake in the business from the founders, with Maudie Derks remaining as CEO and reinvesting alongside the Fund.

Maudie Derks, CEO of Acture Groep, commented: “For over a decade, Acture Groep has established itself as a leader in Dutch social security services and is now the largest private social security provider in The Netherlands. As we enter a period of accelerated growth, we are delighted to partner with IK Investment Partners whose combined experience in the healthcare and tech-enabled business services sectors will be an asset to us as we grow to the next stage. We look forward to working with them as we develop our position and international offering.”

Sander van Vreumingen, Partner at IK and advisor to the IK Small Cap II Fund, commented: “Acture Groep is an impressive collection of products and brands with a track record of success in supporting Dutch employers with the complex task of managing compliance and social security legislation. We believe that the Company and its entrepreneurial leadership team is well-positioned for future growth and look forward to supporting Acture Groep as it embarks on the next phase of its strategy.”

The transaction represents the ninth investment made by the IK Small Cap II Fund.

For further questions, please contact:

IK Investment Partners
Sander van Vreumingen, Partner
Phone: +31 208 909210

Acture Groep
David Gribnau, Gribnau Comunicatie
Phone: +31 35 533 7226

About IK Investment Partners

IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK has raised more than €10 billion of capital and invested in over 130 European companies. IK funds support companies with strong underlying potential, partnering with management teams and investors to create robust, well-positioned businesses with excellent long-term prospects. For more information, visit www.ikinvest.com

Categories: News

Tags:

CVC Credit Partners becomes sole lender to Horizon Capital’s Sabio

The refinancing of the existing debt facility allows CVC Credit Partners to support Sabio in its next stage of growth

CVC Credit Partners is pleased to announce that it has provided a unitranche loan and a dedicated acquisition facility to Sabio, a leading customer experience solutions provider and managed services business, backed by Horizon Capital.

Founded in 1998 and headquartered in the UK, Sabio is a global provider of customer engagement technology and managed services, to blue chip enterprise clients. Sabio helps brands optimise contact centre operational performance and improve the customer experience, structures and strategies. The business operates from 11 offices and employs just over 500 people. Sabio Group is backed by Horizon Capital who invested in 2016 and have supported the business’s tripling in size over the past three years.

Simon Hitchcock, Managing Partner at Horizon, commented: “The refinancing in partnership with CVC Credit means that Sabio can continue its successful organic growth, underpinned by an experienced and supportive lender. Securing this significant new committed acquisition facility means we are able to accelerate the buy and build strategy and in the coming months we expect to complete a number of acquisitions from a strong pan European pipeline.”

Jonathan Gale, CEO of Sabio Group said: “With Horizon and CVC backing the business, Sabio is ideally positioned to continue our growth strategy, building a strong footprint in primary European markets and adding technology and skills to our portfolio. This is an exciting move for Sabio and enables our ongoing strategy to bring the very latest in AI powered, self-service and channel agnostic customer engagement solutions to our fantastic, growing, client base.”

Chris Fowler, Managing Director in CVC Credit Partners’ European Private Debt business, added: “Sabio is a leading technology provider, which operates in a large and growing market driven by increasing investment in digital automation and analytics. Its loyal client base yields high renewal rates and reliable recurring revenues. With Horizon’s backing, Sabio has grown strongly in recent years and we are now pleased to support the business on its next stage of development.”

Categories: News

Tags:

Aptos to be acquired by affiliates of Goldman Sachs’ Merchant Banking Division from Funds advised by Apax Partners

Apax

13 January 2020

Strategic capital commitment from funds managed by Goldman Sachs to fast-track Aptos’ product innovation and retailers’ digital transformation

ATLANTA — Jan. 13, 2020: Aptos today announced that funds affiliated with the Merchant Banking Division of Goldman Sachs have reached a definitive agreement to acquire the company from funds advised by Apax Partners (the “Apax Funds”). Aptos, Inc., a recognized market leader in retail technology solutions, delivers innovative, cloud-native and comprehensive omni-channel solutions to more than 1,000 retail brands in 65 countries.

Aptos to be acquired by affiliates of Goldman Sachs’ Merchant Banking Division from Funds advised by Apax Partners

The Apax Funds backed Aptos CEO Noel Goggin to spin-out the business from portfolio company, Epicor, in 2015. Since then, Aptos has thrived as an independent company having more than doubled their customer base to become one of the largest global enterprise software providers focused exclusively on retail. In addition, the Apax Funds supported Aptos on a number of strategic acquisitions which strengthened Aptos’ presence in Europe and extended its product capabilities.

“Aptos is looking forward to the next stage in our growth and maturation journey in partnering with Goldman Sachs, a group that brings a wealth of enterprise software expertise, commercial relationships and vast global resources,” said Noel Goggin, Aptos CEO and culture leader. “We are also grateful for the strong partnership and strategic support Apax has provided over the past four and a half years.”

“When evaluating the retail software market, it became apparent that Aptos is a leader in delivering differentiating and built-for-the-future innovation,” said Will Chen, Managing Director at Goldman Sachs.

“With the strength of Aptos’ executive team, the company is uniquely positioned to help retailers develop resilient and thriving enterprises that can adapt to shifting consumer trends and market conditions,” Chen said. “We look forward to helping the company further scale the product innovations, customer success initiatives and global market expansions that have been hallmarks of Aptos’ preeminence to date.”

“We would like to thank Noel and his team for all they have achieved. As an independent and entrepreneurial company, Aptos has delivered on its potential by offering a comprehensive “end-to-end” platform at the forefront of the market transition to omni-channel retailing,” said Jason Wright, a Partner at Apax Partners. “We wish them continued success in the future.”

About Aptos “Engaging Customers Differently”

In an era of virtually limitless choice, sustained competitive advantage only comes to retailers who engage customers differently – by truly understanding who they are, what they want and why they buy. At Aptos, we too, believe that Engaging Customers Differently™ is critical to our success. We are committed to a deep understanding of each of our clients, to fulfilling their needs with the retail industry’s most comprehensive omnichannel solutions, and to fostering long-term relationships built on tangible value and trust. More than 1,000 retail brands rely upon our Singular Commerce™ platform to deliver every shopper a personalized, empowered and seamless experience…no matter when, where or how they shop. Learn more: www.aptos.com

Follow Aptos on Twitter @Aptos_Retail

Aptos, the Aptos logo, “Engaging Customers Differently” and “Singular Commerce” are trademarks of Aptos, Inc. All other trademarks referenced are the property of their respective owners.

About Apax Partners

Apax Partners is a leading global private equity advisory firm. Over its more than 40-year history, Apax Partners has raised and advised funds with aggregate commitments of c.$50 billion. The Apax Funds invest in companies across four global sectors of Tech & Telco, Services, Healthcare, and Consumer. These funds provide long-term equity financing to build and strengthen world-class companies. For more information see: www.apax.com.

About Goldman Sachs Merchant Banking Division

Founded in 1869, The Goldman Sachs Group, Inc. is a leading global investment banking, securities and investment management firm. Goldman Sachs Merchant Banking Division (MBD) is the primary center for the firm’s long-term principal investing activity. MBD is one of the leading private capital investors in the world with investments across private equity, infrastructure, private debt, growth equity and real estate.

Media Contacts

For Aptos, Inc.

Kristen Miller | +1 678 695 6566 | kmiller@aptos.com

For Apax Partners

Global Media: Andrew Kenny, Apax | +44 20 7 872 6371 | andrew.kenny@apax.com

USA Media: Todd Fogarty, Kekst CNC | +1 212-521 4854 | todd.fogarty@kekstcnc.com

UK Media: Matthew Goodman / James Madsen, Greenbrook | +44 20 7952 2000 | apax@greenbrookpr.com

For Goldman Sachs

Leslie Shribman | +1 212 902 5400 | leslie.shribman@gs.com

Categories: News

Tags:

3i creates single use bioprocessing platform

3I

3i Group plc (“3i”) today announces that it has established a single use bioprocessing platform serving the biopharmaceutical sector with the acquisitions of Cellon, Silicone Altimex and TBL Performance Plastics.  Cellon, based in Luxembourg, and TBL, based in New Jersey, were acquired from their founder owners, who will continue to serve as key leaders of the platform.  Silicone Altimex had been a UK based subsidiary of 3i-backed Q Holding (“Q”) that was acquired in 2015 from its owners, who remain advisors to the company.

Cellon is a manufacturer of single-use products for bioprocessing, storage, and transport of sterile solutions for pharmaceutical and biotech companies in the production of biological drugs, vaccines and therapies. Its products include sterile bottles for the production of biologic drugs, custom tube and bottle sets and platinum-cured silicone tubing. The company has a 54,000 sq. ft. manufacturing facility in Luxembourg.  Cellon serves leading developers of biologics, vaccines and cell & gene therapies.

TBL is a vertically integrated thermoplastic manufacturer of high purity tubing, sanitary fittings, over-moulded connections and other products for biopharmaceutical production facilities.  It operates a 20,000 sq. ft. facility in Sparta, NJ, where it provides injection moulding, extrusion and ISO Class 7 clean room assembly services.  TBL serves leading OEMs, as well as leading integrators and distributors serving the bioprocessing production market.  Silicone Altimex provides high quality, integrated elastomeric solutions to biopharmaceutical manufacturers.  Its products include a broad range of silicone tubing, clean room assemblies and other components.

As the biopharmaceutical industry continues to transition to single-use bioprocessing technologies (“SUT”) given their flexibility, cleanliness and cost advantage in comparison to stainless steel equipment, manufacturers are seeking partners that can deliver flexible solutions, innovative products and faster turnaround times.  The newly established platform will offer industry leading products, such as the PharmaTainerTM bottles and carboy product line, aSURE® fittings, Tri-Clamp® ends, Bio-EaseTM clamps, a wide range of tubing solutions such as Cellgyn® and cleanroom bioprocessing assembly capacity in North America and Europe for custom solutions. These products support the research, development and commercial production of life saving therapies, accelerating production setup times and time to market with lower required capital investment.

Thomas J. Hook, CEO, Q, said:

“With Cellon and TBL, it became clear we had a unique opportunity to establish a standalone platform in the SUT market.  We believe a dedicated approach is in the best interests of serving the market and the combined customer base of leading biopharma and vaccine manufacturers, integrators and distributors.  Q Holding will be reinvesting proceeds to support a significant expansion of its production capacity for our cardiovascular and peripheral vascular catheter product lines.”

Richard Fry, CEO, Cellon, said:

“We are excited to work with 3i given its international team and shared vision for opportunities to support Cellon’s continued growth and complement its product offering and geographic footprint. We believe they will be a great partner for us as we look to expand our production capacity and portfolio of innovative and high quality products.”

Bob DuPont, CEO, TBL, commented:

“The partnership opportunity between TBL, Cellon and Silicone Altimex is very exciting and significantly expands the portfolio of products and solutions we can provide to the industry.  We look forward to discussing with our customers and partners how we can better serve their needs as a global organisation.”

Richard Relyea, Partner, 3i US, commented:

“3i has been looking for some time to build a platform serving the high growth SUT market. In combining Cellon, TBL and Silicone Altimex we are establishing a platform with a strong product suite of leading SUT solutions and clean room production capacity in North America and Europe.  We will continue to invest in innovation, production capacity and geographic footprint to better serve our customers.”

3i is actively looking for additional opportunities to grow the platform through further acquisitions and organic investment that would enable it to expand its suite of innovative products, increase its capacity and capabilities and better serve its market leading global customers.

 

Categories: News

Tags:

DIF Capital Partners agrees to sell a portfolio of French PPPs

DIF

DIF Capital Partners (“DIF”) is pleased to announce that DIF Infrastructure III (“DIF III”) has agreed to sell a portfolio of eight operational PPPs in France to 3i European Operational Projects Fund.

The portfolio consists of significant shareholdings in three educational facility projects, one multimodal train station project, one fire station project (consisting of 12 fire stations), two prison projects (consisting of three prison facilities each) and one sewer project. The projects are operational under availability-based and long term contracts, with the exception of the sewer concession project, and are all backed by strong public counterparties. Six of the eight projects were developed and acquired by DIF III as greenfield projects, and have been successfully managed into stable operational projects during DIF’s ownership.

Andrew Freeman, Head of Exits, said: “We are pleased with the sale of the portfolio that was successfully optimized throughout the life of the assets and exited via a competitive portfolio sales process. The sale represents a further underpinning of DIF’s long standing track record in the French infrastructure market and is an attractive exit for DIF III.”

DIF was advised by KPMG (M&A, Tax & Accounting), Allen & Overy (Legal) and Currie & Brown (Technical) and Egis (Technical for the sewer project).

Closing of the transaction is subject to receipt of certain customary project-counterparty approvals and antitrust consent.

About DIF Capital Partners

DIF is an independent infrastructure fund manager, with €6.0 billion of assets under management across eight closed-end infrastructure funds and several co-investment vehicles. DIF invests in greenfield and brownfield infrastructure assets located primarily in Europe, the Americas and Australasia through two complementary strategies:

  • DIF Infrastructure funds target equity investments in public-private partnerships (PPP/PFI/P3), concessions, utilities and renewable energy projects with long-term contracted or regulated income streams.
  • DIF CIF funds target equity investments in small to mid-sized infrastructure assets in the energy, transportation and telecom sectors with mid-term contracted income streams.

DIF has a team of over 135 professionals, based in nine offices located in Amsterdam (Schiphol), Frankfurt, London, Luxembourg, Madrid, Paris, Santiago, Sydney and Toronto. Please visit www.dif.eu for further information.

Contact:
Allard Ruijs, Partner
Email: a.ruijs@dif.eu

Categories: News

Tags:

Ardian and OX2 switch to N149/5.X turbines at Swedish 286 MW Åndberg wind farm

Ardian

In December 2019, Ardian, a leading private investment house, and OX2, a leading Nordic developer, signed an agreement with Nordex to utilize more powerful turbines at the Åndberg windfarm

Hamburg, 10 January 2020 – Ardian and Nordic developer OX2 are relying, for the first time, on Nordex turbines of the 5 MW class for the 286 MW wind farm “Åndberg”. The Nordex Group had already booked this order comprising 53 turbines as order intake in 2019, at that time on the basis that N149/4.0-4.5 turbines of the 4-MW class would be used. In December 2019, the customers and Nordex signed a contract for the use of even more powerful turbines at the wind farm. This makes the Åndberg project the first wind farm using the new N149/5.X turbine, which the Nordex Group introduced in March 2019.

Åndberg is currently being constructed in the province of Härjedalen, near Lillhärdal in western Sweden. The wind farm was sold to Ardian, a leading international private investment company, in February 2019 and forms part of their Nordic sustainable energy investment platform, eNordic. Following its completion in 2021, Åndberg will annually provide clean electricity in excess of 800 GWh, making it one of the largest wind farms in Sweden. Developer OX2 delivers the wind farm through an engineering and construction (EPC) agreement with Ardian.

Simo Santavirta, Head of Asset Management, Ardian Infrastructure, says: “These new turbines are innovative engineering, delivering impressive power, flexibility and efficiency. We are always looking to use the very best technological solutions for our assets and these turbines are a good example of this”.

Paul Stormoen, CEO at OX2 says: “We have a long-standing relationship with Nordex and are happy to see them continuing to develop competitive turbines suitable for the growing Nordic market.”

“We are pleased that OX2 has again opted for our wind turbines last year,” says Patxi Landa, CSO of the Nordex Group. “Technologically the N149/5.X is based on the N149/4.0-4.5 turbine type from the Delta4000 series. The N149/5.X can also be flexibly operated in different modes, depending on project requirements – and now in the 5+ MW power range too.”

The Nordex Group – a profile

The Group has installed more than 27 GW of wind energy capacity in over 40 markets and in 2018 generated revenues of EUR 2.5 billion.  The company currently has more than 6,000 employees. The joint manufacturing capacity includes factories in Germany, Spain, Brazil, the United States, India, Argentina and Mexico. The product portfolio is focused on onshore turbines in the 2.4 to 5.X MW class, which are tailor-made for the market requirements of countries with limited space and regions with limited grid capacity.

About OX2

OX2 develops, builds and manages renewable power generation. OX2 has taken a leading position in large-scale onshore wind power over the past 15 years, having generated more than 2 GW of wind power in the Nordic region. By constantly increasing access to renewable energy, OX2 is promoting the transition towards a more sustainable future. OX2 has operations in Sweden, Norway, Finland, Poland, Lithuania, France and Germany. Its head office is located in Stockholm, Sweden. Sales revenue in 2018 amounted to EUR 403 million.
www.ox2.com

About Ardian

Ardian is a world-leading private investment house with assets of US$96bn managed or advised in Europe, the Americas and Asia. The company is majority-owned by its employees. It keeps entrepreneurship at its heart and focuses on delivering excellent investment performance to its global investor base. Through its commitment to shared outcomes for all stakeholders, Ardian’s activities fuel individual, corporate and economic growth around the world. Holding close its core values of excellence, loyalty and entrepreneurship, Ardian maintains a truly global network, with more than 550 employees working from fifteen offices across Europe (Frankfurt, Jersey, London, Luxembourg, Madrid, Milan, Paris and Zurich), the Americas (New York, San Francisco and Santiago) and Asia (Beijing, Singapore, Tokyo and Seoul). It manages funds on behalf of around 800 clients through five pillars of investment expertise: Fund of Funds, Direct Funds, Infrastructure, Real Estate and Private Debt.
www.ardian.com

About eNordic

eNordic is the Nordic’s first sustainable energy platform, formed by a partnership between Ardian, a world-leading private investment house, and leading domestic industry executives. Through a local, responsible and agile investment approach, eNordic enables the transformation of the energy sector through long-term partnerships with those that develop or operate sustainable energy projects in the Nordics. It invests in opportunities in wind, biomass, hydro and district heating, in addition to traditional energy assets that have the potential to be transformed or managed in a particularly sustainable way. eNordic is based in Sweden and Finland, with local teams operating throughout the Nordics region.
www.enordic.fi

For more information, please contact:

Nordex SE
Felix Losada
Phone: +49 (0)40 / 300 30 – 1141
flosada@nordex-online.com

Contacts for investors:

Nordex SE
Felix Zander
Phone: +49 (0)40 / 300 30 – 1116
fzander@nordex-online.com
Ardian/eNordic
Headland
Carl Leijonhufvud
Phone: +44 20 3805 4827
cleijonhufvud@headlandconsultancy.com

Categories: News

Tags:

3i European Operational Projects Fund agrees to acquire a portfolio of eight projects in France and completes investment in AGESA

3I

3i Group plc (“3i”) announces that the 3i European Operational Projects Fund (“3i EOPF” or “the Fund”) has agreed to acquire a portfolio of eight operational projects (the “Portfolio”) in France from DIF Infrastructure III. The Fund has also completed its €70m investment in AGESA, the project company for the Gerediaga-Elorrio motorway PPP in Spain, which was announced on 28 October 2019. Following these transactions, the Fund has deployed c.60% of its total commitments.

Completion of the Portfolio transaction, which is subject to certain conditions including customary antitrust and third party approvals, is expected by the end of Q1 2020.

The Portfolio consists of two batches of three prisons each, three educational projects, one wastewater collection concession, one train station and a batch of 12 fire stations. All projects are fully operational. The projects are availability-based and are backed by strong public counterparties. The wastewater collection concession has a moderate level of demand risk.

Stephane Grandguillaume, Partner at 3i in charge of origination for the Fund, commented: “This is a high quality portfolio with an attractive yield profile consistent with the Fund’s mandate, providing further risk diversification for the Fund.”

3i EOPF, which is managed by 3i’s infrastructure team, is a €456m fund investing in operational projects across Europe, with a focus on France, the Benelux, Germany, Italy and Iberia.  It targets a wide range of sub-sectors, primarily social infrastructure and transportation, but also telecoms and utilities. It aims to provide long-term yield to institutional investors.

 

Categories: News

Tags:

GHO Capital acquires Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma

Mentha Capital

Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, together with the existing management team has acquired Ardena, a specialist contract development and manufacturing organization (CDMO) focused on early phase drug development, from Mentha Capital.

Ardena is a multi-service CDMO, assisting small-to-mid sized biopharma with services spanning the full development life cycle. The Company offers a comprehensive ‘Make, Analyse, File’ model from drug substance and drug product manufacturing and bioanalytical services through to regulatory dossier development. Headquartered in Belgium, the company operates across several sites in the Netherlands, Sweden and Latvia.

With a strong reputation for quality and a flexible service delivery model, Ardena caters to a highly diversified base of over 300 customers throughout Europe, the US, Japan and Korea. A high science approach and broad drug development toolkit differentiate Ardena from peers as a comprehensive multi-service pan-European platform.

With extensive sectoral expertise and network in the global biopharma industry, the GHO team will support management in accelerating Ardena’s plan to enable customers to take a molecule from ‘target to clinic’ with a single outsourced drug development service provider.

GHO plans to further strengthen Ardena’s broad service proposition through organic and inorganic opportunities, adding to both the Company’s offering and international footprint.

The Company is well-positioned to benefit from sector trends as an increasing number of biopharma companies outsource large parts of their early stage drug development work to highly specialised CDMOs.

Harry Christiaens, CEO of Ardena, commented: “With their deep expertise in the Pharma sector, we are excited now to partner with GHO as we continue our international growth. Ardena and GHO are fully committed to the science-led approach that delivers valuable solutions for our biopharma customers globally.”

The Partners at GHO Capital, commented: “We are delighted to have the opportunity to work with the Ardena team. Operating within a highly fragmented market, Ardena is the market leading platform from which to build a fully integrated early stage CDMO, serving Biopharma clients globally.”

Gijs Botman, Partner of Mentha Capital, commented: “Ardena has grown from a Ghent-based business to become a leading early-stage, multi-service CDMO in Western Europe. After successfully completing and integrating four acquisitions, the company is now ready for a new growth phase. We had a fantastic journey with the Ardena team, and we are confident that GHO Capital is the right partner to support their ambitions going forward.”

LinkedIn

Categories: News

Tags:

IK Investment Partners to sell CID Lines

ik-investment-partners

Ecolab Inc. announced today it reached an agreement to acquire the CID Lines group (“the Group”), from the IK VII Fund, advised by IK Investment Partners (IK), and the other shareholders. Completion of the transaction is subject to customary closing conditions, including approvals from applicable competition authorities. CID Lines is a hygiene and health solutions provider, principally focused on the animal health industry.

Founded in Belgium in 1989, CID Lines established itself as a leader in disinfectants for combatting infectious animal diseases. Today, the Group’s product range includes a variety of veterinary medicinal products as well as an extensive range of high-quality, branded biosecurity solutions for disinfection and cleaning procedures in farming environments.

Since partnering with CID Lines in January 2016, IK has supported the execution of a successful strategy that has realised continued strong growth. Through its expanding network, CID Lines serves customers across the globe and continues to enhance its base through its best-in-class commercial capabilities in combination with its excellent research & development and registration capabilities.

Remko Hilhorst, Managing Partner at IK Investment Partners and advisor to the IK VII Fund, commented: “CID Lines has made tremendous progress since we first partnered with them in 2016, cementing their position as a leader in the increasingly important market for biosecurity and immunity products that support reduced use of antibiotics in farm animals. We are grateful to have worked with such a dedicated team of professionals at CID Lines to help the business successfully expand its reach and product range. We wish them every success in the future and look forward to seeing how the Company develops.”

Koen Brutsaert, founder and CEO at CID Lines commented: “CID Lines showed excellent growth the last three years. The drivers behind this growth were continued investments in new products, registrations and our salesforce.  IK has been very supportive of these investments in our growth, and we would like to thank them for this support.”

For further questions, please contact:

IK Investment Partners
Remko Hilhorst, Managing Partner
+31 208 909210

About IK Investment Partners
IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK has raised more than €10 billion of capital and invested in over 130 European companies. IK funds support companies with strong underlying potential, partnering with management teams and investors to create robust, well-positioned businesses with excellent long-term prospects. For more information, visit www.ikinvest.com

About CID Lines
Founded in Belgium in 1989, CID established itself as a leader in disinfectants for combatting infectious animal diseases. Today, the Group’s product range includes a variety of veterinary medicinal products as well as an extensive range of high-quality, branded biosecurity solutions for disinfection and cleaning procedures in farming environments.

Categories: News

Tags:

EURAZEO succesfully renews and increases its syndicated credit line to €1.5BILLION

Eurazeo

FOR THE FIRST TIME IN THE CAPITAL MARKET,THE MARGIN AGREED ON THIS FACILITY IS INDEXED ON ESG CRITERIA

Paris, January 9, 2020–Eurazeo, a leading global investment company, has successfully renewed its credit line with a consortium of 13banks. The size of the facility was increased by 50% (the amount rose to €1.5billion, up from €1billion previously), which will be an additional advantage on Eurazeo’s ambitions. The renewal also offers the Group greater visibility over the next five years, with two options to extend the duration each by an additional period of a year, subject to approval by the lenders, therefore resulting in a total duration of seven years.

Furthermore, for the first time in the credit market in EMEA, this new facility has been indexed against ESG performance criteria.

If the criteria are fulfilled, the margin calculation will give rise to savings on fees that Eurazeo has pledged to put toward funding projects to reduce greenhouse gas emissions, for which the environmental quality and integrity will be guaranteed by the most rigorous labels and certifications. If the criteria are not fulfilled, the additional fees the banks would be entitled to charge Eurazeo would also be allocated to such projects.This innovative financial arrangement reflects a desire to work together to facilitate the emergence of new sustainable financial products.

The operation is fully in line with Eurazeo’s ESG strategy, which strives to combine value creation with social responsibility throughout the entire investment cycle. Eurazeo is the only capital investment firm to be included in five benchmark ESG indices alongside the world’s top performing companies in terms of CSR: Ethibel Sustainability Index (ESI), Euronext Vigeo, FTSE4Good, MSCI ESG and Low Carbon Leaders and STOXX Sustainability, Low Carbon and ESG Leaders.

Philippe Audouin, CFO of Eurazeo, stated:“The successful renewal of our credit line demonstrates the trust our banking partners have in Eurazeo. We are also very proud to see Eurazeo become the first capital investment firm to put in place an agreement to redirect a portion of the fees to ESG projects. Eurazeo has long been a pioneer in its market, having integrated CSR considerations into all stages of its investment process back in 2008. As a catalyst of transformation for business, the capital investment market is ideally placed to make a significant contribution.”

EURAZEO CONTACTS PRESS CONTACT PIERRE BERNARDIN Head of Investor Relations

email: pbernardin@eurazeo.com Tel: +33 (0)1 44 15 16 76

VIRGINIE CHRISTNACHT Head of Communications email: vchristnacht@eurazeo.com Tel: +33 1 44 15 76 44MAITLAND/amoDAVID STURKEN email: dsturken@maitland.co.uk Tel: +44 (0) 7990 595 913

For more information, please visit the Group’s website: www.eurazeo.comFollow us on Twitter,Linkedin, and YouTube

The consortium is made up of the following banks:-as MLAs & Bookrunners: BNP Paribas, Cacib, CIC, Natixis and Société Générale -as MLAs: Banque Palatine, Barclays, CADIF, Citibank, Crédit Lyonnais, Goldman Sachs, Intesa San Paolo, JP Morgan, Mediobanca, NatWest Markets and Royal Bank of Canada,-BNP Paribas as CSR Coordinator, Natixis as bookrunner and Cacib as the underwriter.***

About Eurazeo

Eurazeo is a leading global investment company, with a diversified portfolio of €18billion in assets under management, including €12billion from third parties, invested in over 400 companies. With its considerable private equity, venture capital, real estate, private debt and fund of funds expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its 235 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term. Eurazeo has offices in Paris, New York, Sao Paulo, Seoul, Shanghai, London, Luxembourg, Frankfurt, Madrid and Berlin

Eurazeo is listed on Euronext Paris.oISIN: FR0000121121 -Bloomberg: RF FP -Reuters: EURA.PA

Categories: News